Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

BACKGROUND: Estimates of the risk of developing Crohn's disease (CD) can be made using DNA testing for mutations in the NOD2 (CARD15) gene, family history, and smoking status. Smoking doubles the risk of CD, a risk that is reduced by stopping. CD therefore serves as a timely and novel paradigm...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Whitwell, Sophia CL, Mathew, Christopher G, Lewis, Cathryn M, Forbes, Alastair, Watts, Sally, Sanderson, Jeremy, Hollands, Gareth J, Prevost, A Toby, Armstrong, David, Kinmonth, Ann Louise, Sutton, Stephen, Marteau, Theresa M
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2011
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3036624/
https://ncbi.nlm.nih.gov/pubmed/21247480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2458-11-44
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki